No connection

Search Results

UG

NEUTRAL
$6.66 Live
United-Guardian, Inc. · NASDAQ
$5.58 52W Range $9.88

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 22, 2026
Market cap
$30.6M
P/E
14.48
ROE
18.2%
Profit margin
20.0%
Debt/Equity
N/A
Dividend yield
7.51%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
United-Guardian exhibits a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health despite strong current margins and growth. While the company shows impressive revenue (19.6%) and earnings (29%) growth and a strategic partnership with Brenntag, the dividend is unsustainable with a payout ratio of 130.43%. The stock trades between its defensive Graham Number ($5.03) and growth-based intrinsic value ($13.57), but long-term price performance remains bearish.

Key Strengths

Strong profitability margins (Gross: 48.75%, Operating: 24.37%)
Robust short-term liquidity with a Current Ratio of 7.31
Strong YoY growth in both revenue (19.6%) and earnings (29%)
Strategic distribution agreement with Brenntag Specialties for global expansion
Reasonable P/E ratio (14.48) relative to the Consumer Defensive sector average

Key Risks

Unsustainable dividend payout ratio of 130.43%, signaling a high risk of dividend cut
Weak Piotroski F-Score (3/9) suggesting poor fundamental health trends
Severe long-term price erosion (5Y Change: -41.4%)
Micro-cap volatility and lack of analyst coverage
Execution risk associated with the new sexual wellness product line
AI Fair Value Estimate
Based on comprehensive analysis
$7.5
+12.6% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
42
Moderate
Value
65
Future
75
Past
20
Health
30
Dividend
20
AI Verdict
Speculative Hold
Key drivers: Strong growth metrics, Poor fundamental health score, Unsustainable dividend, Bearish technical trend
Confidence
80%
Value
65/100

Ref P/E 14.48, PEG 1.12, Graham Number $5.03

Positives
  • P/E is lower than sector average
  • PEG ratio of 1.12 suggests fair valuation relative to growth
Watchpoints
  • Trading above the Graham Number ($5.03)
Future
75/100

Ref Growth rates and 10-K distribution agreement

Positives
  • High YoY earnings growth (29%)
  • New distribution partnership in North America and France
Watchpoints
  • Reliance on unproven sexual wellness sales for 2026
Past
20/100

Ref Historical price performance

Positives
  • Recent 1-month positive price movement (+6.2%)
Watchpoints
  • Consistent multi-year decline (1Y, 3Y, 5Y all negative)
  • Technical trend score of 0/100
Health
30/100

Ref Piotroski F-Score 3/9

Positives
  • Extremely high current and quick ratios
Watchpoints
  • Piotroski F-Score of 3/9 indicates weak financial health
Dividend
20/100

Ref Yield 7.51%, Payout 130.43%

Positives
  • High nominal yield of 7.51%
Watchpoints
  • Payout ratio of 130.43% is fundamentally unsustainable

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$6.66

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for UG and closest competitors.

Updated 2026-04-21
UG
United-Guardian, Inc.
Primary
5Y
-41.4%
3Y
-20.1%
1Y
-17.0%
6M
-9.3%
1M
+6.2%
1W
+1.8%
AAC
ATA Creativity Global
Peer
5Y
-78.8%
3Y
-48.4%
1Y
+4.2%
6M
-53.5%
1M
+6.5%
1W
+2.1%
JVA
Coffee Holding Co., Inc.
Peer
5Y
-9.5%
3Y
+115.1%
1Y
+44.1%
6M
+8.0%
1M
+41.2%
1W
+9.1%
BOF
BranchOut Food Inc.
Peer
5Y
-32.3%
3Y
-32.3%
1Y
+52.3%
6M
+20.5%
1M
-11.0%
1W
-9.9%
RMC
Rocky Mountain Chocolate Factory, Inc.
Peer
5Y
-62.0%
3Y
-57.8%
1Y
+74.4%
6M
+36.4%
1M
-2.2%
1W
+7.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
14.48
Forward P/E
N/A
PEG Ratio
1.12
P/B Ratio
2.72
P/S Ratio
2.9
EV/Revenue
2.09
EV/EBITDA
9.37
Market Cap
$30.6M

Profitability

Profit margins and return metrics

Profit Margin 19.97%
Operating Margin 24.37%
Gross Margin 48.75%
ROE 18.22%
ROA 10.42%

Growth

Revenue and earnings growth rates

Revenue Growth +19.6%
Earnings Growth +29.0%
Q/Q Revenue Growth +19.59%
Q/Q Earnings Growth +29.0%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
7.31
Strong
Quick Ratio
6.09
Excellent
Cash/Share
$1.87

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
45.0%
Op. Margin
24.4%
Net Margin
21.9%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.17x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
93%

Consumer Defensive Sector Comparison

Comparing UG against 128 companies in the Consumer Defensive sector (9 bullish, 49 neutral, 70 bearish)
P/E Ratio
14.48
This Stock
vs
36.07
Sector Avg
-59.9% (Discount)
Return on Equity (ROE)
18.22%
This Stock
vs
-21.53%
Sector Avg
-184.6% (Below Avg)
Profit Margin
19.97%
This Stock
vs
-7.96%
Sector Avg
-350.8% (Weaker)
Revenue Growth
19.6%
This Stock
vs
147.67%
Sector Avg
-86.7% (Slower)
Current Ratio
7.31
This Stock
vs
2.38
Sector Avg
+206.5% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

GLOBUS KENNETH H
Director
Gift
2026-01-21
7,480 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
FORM DEF 14A
2026-04-06

UG filed a definitive proxy statement on April 6, 2026, providing shareholders with necessary information to vote on corporate matters at the upcoming annual meeting.

10-K
FORM 10-K
2026-03-27

UG specializes in cosmetic, personal care, and healthcare products, recently securing a distribution agreement with Brenntag Specialties to expand its Natrajel and Lubrajel lines across North America and France. While the company reported no sales of sexual wellness products in 2025, this partnership is intended to drive growth in these key markets. Risks include general uncertainties associated with forward-looking statements and the execution of new distribution strategies.

8-K
FORM 8-K
2026-03-27

Unity Software Inc. filed a current report on March 27, 2026, likely announcing its first-quarter financial results.

8-K
FORM 8-K
2026-01-29

Unity Software Inc. filed an 8-K on January 29, 2026, likely to announce its fourth quarter and full-year financial results.

10-Q
FORM 10-Q
2025-11-06

United-Guardian, Inc. filed its Form 10-Q on November 6, 2025, which includes disclosures regarding risk factors and unregistered sales of equity securities. No specific financial performance metrics or detailed risk descriptions were provided in the available excerpt.

8-K
FORM 8-K
2025-11-06

Unity Software Inc. filed an 8-K on November 6, 2025, likely to announce its third-quarter financial results.

10-Q
FORM 10-Q
2025-08-08

United-Guardian, Inc. filed its Form 10-Q on August 8, 2025, which includes disclosures regarding risk factors and unregistered sales of equity securities. Specific financial highlights and detailed risk descriptions were not provided in the available excerpt.

8-K
FORM 8-K
2025-08-08

Unity Software Inc. (UG) filed an 8-K on August 8, 2025, likely to announce its second-quarter financial results.

8-K
FORM 8-K
2025-07-15

Unity Software Inc. (UG) filed an 8-K likely announcing its second-quarter financial results.

8-K
FORM 8-K
2025-05-21
8-K
FORM 8-K
2025-05-16
10-Q
FORM 10-Q
2025-05-13
8-K
FORM 8-K
2025-05-08
DEF 14A
DEFINITIVE PROXY STATEMENT
2025-04-07
10-K
FORM 10-K
2025-03-21
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning UG from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile